WisdomTree BioRevolution Fund Rating → The Long-Awaited End of America Update (From Stansberry Research) (Ad) Free WDNA Stock Alerts $15.67 +0.33 (+2.15%) (As of 05/1/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy2.68Holdings in WDNA have an aggregate rating of Moderate Buy based on 541 analyst ratings issued in the past year covering 47 companies (66.3% of the portfolio).WDNA Aggregate Price Target$21.7238.58% UpsideHigh Prediction$28.56Average Prediction$21.72Low Prediction$15.53Holdings in WDNA have an aggregate price target of $21.72 and a range of $15.53 to $28.56 covering 47 companies (66.3% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold12 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 WDNA Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.58%TWSTTwist Bioscience$31.63-1.0%3 of 5 stars3.00$36.40 15.1%42.43%BPMCBlueprint Medicines$109.04+14.9%1 of 5 stars2.50$91.57 -16.0%14Analyst ReportNews CoverageGap Up2.36%IOVAIovance Biotherapeutics$12.68+1.4%5 of 5 stars3.00$24.64 94.3%10Upcoming EarningsShort Interest ↑News CoverageGap Up2.27%GERNGeron$3.96-2.9%4 of 5 stars2.80$6.10 54.0%5Analyst ReportShort Interest ↑News Coverage2.17%NTRANatera$93.56-0.6%2 of 5 stars3.00$86.40 -7.7%14Upcoming EarningsAnalyst UpgradeInsider Selling2.11%LLYEli Lilly and Company$758.16-2.4%5 of 5 stars2.84$757.95 0.0%19Earnings ReportAnalyst ReportAnalyst Revision2.09%VCELVericel$47.50+0.9%1 of 5 stars3.00$46.40 -2.3%6Upcoming Earnings1.73%AGIOAgios Pharmaceuticals$34.82+3.4%1 of 5 stars2.50$33.50 -3.8%4News Coverage1.70%FATEFate Therapeutics$4.094 of 5 stars2.08$6.73 64.5%12Short Interest ↑1.67%SRPTSarepta Therapeutics$131.69+0.6%4 of 5 stars2.79$156.60 18.9%14Earnings ReportAnalyst ReportAnalyst RevisionNews CoverageGap Up1.64%BBIOBridgeBio Pharma$27.64+2.3%5 of 5 stars2.80$47.82 73.0%10Short Interest ↑News CoverageGap Up1.42%DHRDanaher$246.34-0.2%5 of 5 stars2.64$267.31 8.5%141.41%CTLTCatalent$56.41+0.7%3 of 5 stars2.15$52.46 -7.0%13Positive News1.40%VRTXVertex Pharmaceuticals$400.84-0.3%4 of 5 stars2.48$429.45 7.1%23Upcoming Earnings1.40%MRKMerck & Co., Inc.$129.04+0.2%5 of 5 stars2.58$131.33 1.8%12Earnings ReportAnalyst Revision1.38%DARDarling Ingredients$42.89+2.2%5 of 5 stars2.80$72.55 69.1%10Earnings Report1.37%CRSPCRISPR Therapeutics$54.90+2.0%3 of 5 stars2.38$76.29 39.0%161.36%RAREUltragenyx Pharmaceutical$43.66+0.8%4 of 5 stars2.92$88.08 101.7%121.31%DOWDOW$56.85-0.7%4 of 5 stars2.29$59.00 3.8%14Earnings ReportOptions Volume1.31%REGNRegeneron Pharmaceuticals$936.15+3.6%4 of 5 stars2.70$977.77 4.4%20Analyst DowngradeInsider Selling1.30%IONSIonis Pharmaceuticals$43.21+0.5%4 of 5 stars2.69$56.08 29.8%13Upcoming Earnings1.29%FOLDAmicus Therapeutics$10.41-0.2%4 of 5 stars3.00$20.00 92.1%3Upcoming EarningsNews Coverage1.28%ARCTArcturus Therapeutics$26.29-5.8%2 of 5 stars3.00$61.33 133.3%7Upcoming EarningsNews Coverage1.27%AMGNAmgen$277.04-0.1%5 of 5 stars2.53$297.40 7.3%191.26%DDDuPont de Nemours$77.29-1.3%5 of 5 stars2.27$77.90 0.8%11Earnings ReportAnalyst ReportNews Coverage1.26%TSNTyson Foods$61.03+1.2%4 of 5 stars2.11$58.80 -3.7%9Upcoming Earnings1.25%TMOThermo Fisher Scientific$570.83-0.7%5 of 5 stars2.71$607.35 6.4%17Analyst ReportInsider Selling1.22%RGENRepligen$163.61+3.3%4 of 5 stars2.89$196.70 20.2%9Earnings ReportNews Coverage1.22%AAgilent Technologies$137.87-0.6%4 of 5 stars2.59$141.29 2.5%17Gap Up1.22%GMABGenmab A/S$27.74-3.5%3 of 5 stars2.38$48.50 74.8%13Upcoming EarningsAnalyst ReportShort Interest ↑1.21%AZNAstraZeneca$75.99-0.5%2 of 5 stars2.57$81.00 6.6%7Short Interest ↑Analyst Revision1.19%STOKStoke Therapeutics$11.83+2.3%4 of 5 stars2.88$20.71 75.1%81.15%UTHRUnited Therapeutics$259.61+1.8%5 of 5 stars2.89$294.25 13.3%10Earnings ReportAnalyst ReportInsider SellingNews Coverage1.13%QGENQiagen$42.77-0.1%4 of 5 stars2.56$50.95 19.1%9Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage1.13%EXASExact Sciences$60.75+1.2%4 of 5 stars2.86$97.44 60.4%14Upcoming Earnings1.12%RGNXREGENXBIO$16.53+2.0%4 of 5 stars2.83$38.45 132.6%12Upcoming EarningsNews Coverage1.12%NEONeoGenomics$14.28+2.3%3 of 5 stars2.82$19.78 38.5%11Analyst ReportNews Coverage1.12%CTVACorteva$57.22+6.1%5 of 5 stars2.71$63.29 10.6%21Earnings ReportDividend AnnouncementAnalyst ReportNews CoverageGap Up1.11%ZTSZoetis$168.35+6.2%5 of 5 stars3.00$216.13 28.4%7Earnings ReportAnalyst ReportAnalyst RevisionNews CoverageGap Up1.11%JNJJohnson & Johnson$149.55-1.1%5 of 5 stars2.46$175.86 17.6%131.09%VCYTVeracyte$20.36+1.1%4 of 5 stars2.60$29.00 42.4%5Upcoming Earnings1.07%LHLaboratory Co. of America$200.29-0.5%5 of 5 stars2.79$243.14 21.4%14Earnings ReportInsider SellingAnalyst Revision1.05%MYGNMyriad Genetics$19.37-0.5%3 of 5 stars2.33$23.17 19.6%6Upcoming Earnings1.02%ILMNIllumina$124.49-0.2%5 of 5 stars2.32$167.70 34.7%191.00%SANASana Biotechnology$9.91+2.9%1 of 5 stars2.75$11.67 17.7%4News Coverage1.00%CRBUCaribou Biosciences$3.61-2.2%1 of 5 stars2.75$22.50 523.3%4Short Interest ↑1.00%BEAMBeam Therapeutics$22.81+4.9%2 of 5 stars2.38$41.00 79.7%13Upcoming EarningsNews Coverage This page (BATS:WDNA) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDollar CancelledLear CapitalUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
